Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Blann

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|March 1, 1985
Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteinsD R Blake, P Winyard, D G Scott, et al.
Clinical Science (London, England : 1979)|May 1, 1983
Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patientsD R Blake, A Blann, P A Bacon, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Postural variation in von Willebrand factor antigenA Blann, M I Jayson, M H Pope, et al.
Coronary Artery Disease|October 1, 1993
Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplastyA Blann, H Midgley, G Burrows, et al.
Journal of Human Hypertension|November 1, 1994
Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damageW Y Tse, S R Maxwell, H Thomason, et al.
Thrombosis and Haemostasis|April 1, 1997
Soluble adhesion molecules and endothelial cell damage in HIV infected patientsM Seigneur, J Constans, A Blann, et al.
Rheumatology (Oxford, England)|September 19, 2001
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetineB Coleiro, S E Marshall, C P Denton, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsiaF Bretelle, F Sabatier, A Blann, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|March 1, 1985
Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteinsD R Blake, P Winyard, D G Scott, et al.
Clinical Science (London, England : 1979)|May 1, 1983
Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patientsD R Blake, A Blann, P A Bacon, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Postural variation in von Willebrand factor antigenA Blann, M I Jayson, M H Pope, et al.
Coronary Artery Disease|October 1, 1993
Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplastyA Blann, H Midgley, G Burrows, et al.
Journal of Human Hypertension|November 1, 1994
Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damageW Y Tse, S R Maxwell, H Thomason, et al.
Thrombosis and Haemostasis|April 1, 1997
Soluble adhesion molecules and endothelial cell damage in HIV infected patientsM Seigneur, J Constans, A Blann, et al.
Rheumatology (Oxford, England)|September 19, 2001
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetineB Coleiro, S E Marshall, C P Denton, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsiaF Bretelle, F Sabatier, A Blann, et al.
Pageof 5